Recorlev and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Recorlev (levoketoconazole), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Vitamin D3, and have Cushing's syndrome.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Recorlev. It is created by eHealthMe based on reports of 225 people who have side effects when taking Recorlev from the FDA, and is updated regularly.

What is Recorlev?

Recorlev has active ingredients of levoketoconazole. eHealthMe is studying from 226 Recorlev users. Check the latest studies of Recorlev.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,550 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Jul, 10, 2026

225 people reported to have side effects when taking Recorlev.
Among them, 13 people (5.78%) have Hyperhidrosis.

Among these 13 people:

How long have people been on Recorlev when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Recorlev? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperhidrosis when taking Recorlev? *

What are other drugs people take besides Recorlev? *

What are other side effects people have besides Hyperhidrosis? *

Nausea (feeling of having an urge to vomit): 13 people, 100.00%
Fatigue (feeling of tiredness): 11 people, 84.62%
Nausea And Vomiting: 9 people, 69.23%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 53.85%
Feeling Hot: 7 people, 53.85%
Insomnia (sleeplessness): 6 people, 46.15%
Dry Skin: 5 people, 38.46%
Joint Pain: 5 people, 38.46%
Stress And Anxiety: 5 people, 38.46%
Weight Decreased: 5 people, 38.46%

What are the existing conditions these people have? *

Cushing's Syndrome (obesity, a rounded face, increased fat): 11 people, 84.62%
Stress And Anxiety: 4 people, 30.77%
Pituitary Tumor Benign: 2 people, 15.38%
Pain: 2 people, 15.38%
Nausea And Vomiting: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Hypokalemia (low potassium): 2 people, 15.38%
Ectopic Acth Syndrome (a type of cancer-usually associated with the lung): 2 people, 15.38%
Dyspnea (difficult or laboured breathing): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Recorlev and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Recorlev:

Recorlev (226 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

Browse all side effects of Recorlev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,550 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levoketoconazole (the active ingredients of Recorlev) and Recorlev (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.